\u767a\u520a\u6e08\u306e\u3082\u306e\u306fabstract\u307e\u305f\u306f\u672c\u6587\u306b\u30ea\u30f3\u30af\u3057\u3066\u3042\u308a\u307e\u3059\u3002
\nPublished papers are linked to PubMed<\/p>\n
<\/p>\n
Rowan AG, Suemori K, Fujiwara H, Yasukawa M, Tanaka Y, Taylor GP, Bangham C.<\/a><\/p>\n Cytotoxic T lymphocyte lysis of HTLV-1 infected cells is limited by weak HBZ protein expression, but non-specifically enhanced on induction of Tax expression.<\/p>\n Retrovirology. 2014 Dec 14;11(1):116. [Epub ahead of print]<\/p>\n Ochi F, Fujiwara H, Tanimoto K, Asai H, Miyazaki Y, Okamoto S, Mineno J, Kuzushima K, Shiku H, Barrett J, Ishii E, Yasukawa M.<\/a><\/p>\n Gene-modified human \u03b1\/\u03b2-T cells expressing a chimeric CD16-CD3\u03b6 receptor as adoptively transferable effector cells for anticancer monoclonal antibody therapy.<\/p>\n Cancer Immunol Res. 2014 Mar;2(3):249-62.<\/p>\n Ohkubo N, Matsubara E, Yamanouchi J, Akazawa R, Aoto M, Suzuki Y, Sakai I, Abe T, Kiyonari H, Matsuda S, Yasukawa M, Mitsuda N.<\/a><\/p>\n Abnormal behaviors and developmental disorder of hippocampus in zinc finger protein 521 (ZFP521) mutant mice.<\/p>\n PLoS One. 2014 Mar 27;9(3):e92848.<\/p>\n Yamanouchi J, Hato T, Niiya T, Sato Y, Onishi S, Yasukawa M.<\/a><\/p>\n Development of exogenous FVIII-specific inhibitor in a mild haemophilia patient with Glu272Lys mutation.<\/p>\n Haemophilia. 2014 Mar;20(2):e179-82.<\/p>\n Asai H, Fujiwara H, Kitazawa S, Kobayashi N, Ochi T, Miyazaki Y, Ochi F, Akatsuka Y, Okamoto S, Mineno J, Kuzushima K, Ikeda H, Shiku H, Yasukawa M.<\/a><\/p>\n Adoptive transfer of genetically engineered WT1-specific cytotoxic T lymphocytes does not induce renal injury.<\/p>\n J Hematol Oncol. 2014 Jan 6;7(1):3.<\/p>\n Takahashi T, Maeda K, Suzuki T, Ishido A, Shigeoka T, Tominaga T, Kamei T, Honda M, Ninomiya D, Sakai T, Senba T, Kaneyuki S, Sakaguchi S, Satoh A, Hosokawa T, Kawabe Y, Kurihara S, Izumikawa K, Kohno S, Azuma T, Suemori K, Yasukawa M, Mizutani T, Omatsu T, Katayama Y, Miyahara M, Ijuin M, Doi K, Okuda M, Umeki K, Saito T, Fukushima K, Nakajima K, Yoshikawa T, Tani H, Fukushi S, Fukuma A, Ogata M, Shimojima M, Nakajima N, Nagata N, Katano H, Fukumoto H, Sato Y, Hasegawa H, Yamagishi T, Oishi K, Kurane I, Morikawa S, Saijo M.<\/a><\/p>\n The first identification and retrospective study of Severe Fever with Thrombocytopenia Syndrome in Japan.<\/p>\n J Infect Dis. 2014 Mar;209(6):816-27.<\/p>\n Yamanouchi J, Hato T, Niiya T, Azuma T, Yasukawa M.<\/a><\/p>\n Severe immune thrombocytopenia secondary to Waldenstr\u00f6m\u2019s macroglobulinemia with anti-GPIb\/IX monoclonal IgM antibody.<\/p>\n Ann Hematol. 2014 Apr;93(4):711-2.<\/p>\n Tanaka S, Suto A, Iwamoto T, Kashiwakuma D, Kagami S, Suzuki K, Takatori H, Tamachi T, Hirose K, Onodera A, Suzuki J, Ohara O, Yamashita M, Nakayama T, Nakajima H.<\/a><\/p>\n Sox5 and c-Maf cooperatively induce Th17 cell differentiation via ROR\u03b3t induction as downstream targets of Stat3.<\/p>\n J Exp Med. 2014 Aug 25;211(9):1857-74.<\/p>\n Kuwahara M, Suzuki J, Tofukuji S, Yamada T, Kanoh M, Matsumoto A, Maruyama S, Kometani K, Kurosaki T, Ohara O, Nakayama T, Yamashita M.<\/a><\/p>\n The Menin-Bach2 axis is critical for regulating CD4 T-cell senescence and cytokine homeostasis.<\/p>\n Nat Commun. 2014 Apr 2;5:3555.<\/p>\n Tanimoto K, Muranski P, Miner S, Fujiwara H, Kajigaya S, Keyvanfar K, Hensel N, Barrett AJ, Melenhorst JJ.<\/a><\/p>\n Genetically engineered fixed K562 cells: potent \u201coff-the-shelf\u201d antigen-presenting cells for generating virus-specific T cells.<\/p>\n Cytotherapy. 2014 Jan;16(1):135-46.<\/p>\n Fujiishi K, Kitazawa R, Nagai Y, Watanabe T, Bando K, Kobayashi S, Yakushijin Y, Haraguchi R, Kitazawa S.<\/a><\/p>\n Acquisition of MYD88 L265P mutation during treatment of diffuse large B cell lymphoma of the parotid gland.<\/p>\n Virchows Arch. 2014 Jan;464(1):121-4.<\/p>\n Shikata H, Yakushijin Y, Yamanouchi J, Azuma T, Yasukawa M.<\/a><\/p>\n Analysis of chemotherapy-induced neutropenia and optimal timing for prophylactic use of G-CSF in B-cell non-Hodgkin lymphoma patients treated with R-CHOP.<\/p>\n Int J Clin Oncol. 2014 Feb;19(1):178-85.<\/p>\n Ichinose A, Souri M, Osaki T, Matsushita T, Urano T, Ieko M, Tamai Y, Ito T, Kawamae K, Yamamoto M, Madoiwa S, Kurosawa H, Ogawa Y, Yatomi Y, Hanafusa N, Kawasugi K, Ishida F, Kitajima I, Asakura H, Hosono N, Mouri H, Kobayashi T, Wada H, Miyata S, Kashiwagi H, Ikeda M, Yukawa M, Higasa S, Hato T, Okamoto K, Okamura T, Uchiba M, Hashiguchi T, Maruyama I.<\/a><\/p>\n Inhibitors of Factor XIII\/13 in older patients.<\/p>\n Semin Thromb Hemost. 2014 Sep;40(6):704-11.<\/p>\n Ishizaki J, Saito K, Nawata M, Mizuno Y, Tokunaga M, Sawamukai N, Tamura M, Hirata S, Yamaoka K, Hasegawa H, Tanaka Y.<\/a><\/p>\n Low complements and high titre of anti-Sm antibody as predictors of histopathologically proven silent lupus nephritis without abnormal urinalysis in patients with systemic lupus erythematosus.<\/p>\n Rheumatology (Oxford). 2014 Sep 2. pii: keu343. [Epub ahead of print]<\/p>\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n